Table 1. Antibodies for immunostaining and results for the present case.
Antibody | Clone | Source | Dilution | Immunoreactivity | ||
|---|---|---|---|---|---|---|
Ovarian carcinoma | Breast tumor | |||||
Mucinous, endocervical type (seromucinous) | Serous, low grade | |||||
WT1 | WT49 | Leica | 1/30 | (+) | (+++) | (+++) |
PAX8 | BC12 | Nichirei | RTU | (+) | (+++) | (+++) |
CA125 | M11 | Dako | 1/50 | (+++) | (+++) | (+++) |
p53 | DO-7 | Dako | 1/2000 | wild type | wild type | wild type |
ER | SP1 | Ventana | RTU | (+++) | (+++) | (+++) |
PgR | 1E2 | Ventana | RTU | (++) | (+) | (−) |
GATA3 | HG3-31 | Santa Cruz | 1/50 | (−) | (−) | (−) |
Mammaglobin | 304-1A5 | Dako | 1/500 | (−) | (−) | (−) |
GCDFP15 | D6 | BioLegend | 1/500 | (−) | (−) | (−) |
HER2 | 4B5 | Ventana | RTU | (−) | (−) | (−) |
Ki67 | MIB1 | Dako | 1/50 | 15% | 15% | 15% |